Allosteric small molecule modulators of nuclear receptors

Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular and cellular endocrinology 2019-04, Vol.485, p.20-34
Hauptverfasser: Meijer, Femke A., Leijten-van de Gevel, Iris A., de Vries, Rens M.J.M., Brunsveld, Luc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 34
container_issue
container_start_page 20
container_title Molecular and cellular endocrinology
container_volume 485
creator Meijer, Femke A.
Leijten-van de Gevel, Iris A.
de Vries, Rens M.J.M.
Brunsveld, Luc
description Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry to address the need for small molecules targeting NRs in pathology, via novel modes of action and with beneficial profiles. In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs. Subsequently, the review focuses on examples of small molecules that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain. Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention. The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small molecular targeting of NRs. [Display omitted] •Allosteric small molecule modulation has emerged as novel entry to targeting NRs.•Inspiration for allosteric NR modulation can be found in other receptor classes.•Allosteric NR modulators harbor the potential for providing novel NR pharmacology.•Screening assays focused on identifying allosteric NR modulators are needed.
doi_str_mv 10.1016/j.mce.2019.01.022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179437669</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303720719300346</els_id><sourcerecordid>2179437669</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-699749063eae16391b275baea8f717cee58d8119c7845887a5df7a7dcbb2b1c43</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7rr6A7xIj15aJ0nbSfAk4hcseNFzSNMpdEm3a9IK_nuzrHr0NMPwvC_Mw9glh4IDr282xeCoEMB1AbwAIY7YkisUuYIKj9kSJMgcBeCCncW4AQCshDplCwkIslS4ZPrO-zFOFHqXxcF6nw2jJzd7Sks7ezuNIWZjl21n58mGLJCj3f54zk466yNd_MwVe398eLt_ztevTy_3d-vcSV1Pea01lhpqSZZ4LTVvBFaNJas65OiIKtUqzrVDVVZKoa3aDi22rmlEw10pV-z60LsL48dMcTJDHx15b7c0ztEIjrqUWNc6ofyAujDGGKgzu9APNnwZDmZvzGxMMmb2xgxwk4ylzNVP_dwM1P4lfhUl4PYAUHrys6dgoutp66jtk4vJtGP_T_03_BV7gA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179437669</pqid></control><display><type>article</type><title>Allosteric small molecule modulators of nuclear receptors</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Meijer, Femke A. ; Leijten-van de Gevel, Iris A. ; de Vries, Rens M.J.M. ; Brunsveld, Luc</creator><creatorcontrib>Meijer, Femke A. ; Leijten-van de Gevel, Iris A. ; de Vries, Rens M.J.M. ; Brunsveld, Luc</creatorcontrib><description>Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry to address the need for small molecules targeting NRs in pathology, via novel modes of action and with beneficial profiles. In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs. Subsequently, the review focuses on examples of small molecules that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain. Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention. The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small molecular targeting of NRs. [Display omitted] •Allosteric small molecule modulation has emerged as novel entry to targeting NRs.•Inspiration for allosteric NR modulation can be found in other receptor classes.•Allosteric NR modulators harbor the potential for providing novel NR pharmacology.•Screening assays focused on identifying allosteric NR modulators are needed.</description><identifier>ISSN: 0303-7207</identifier><identifier>EISSN: 1872-8057</identifier><identifier>DOI: 10.1016/j.mce.2019.01.022</identifier><identifier>PMID: 30703487</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Allosteric Regulation - drug effects ; Allosteric Site ; Allostery ; Binding Sites ; Drug Design ; Drug discovery ; Gene Expression Regulation - drug effects ; Humans ; Ligands ; Nuclear receptors ; Receptors, Cytoplasmic and Nuclear - chemistry ; Receptors, Cytoplasmic and Nuclear - metabolism ; Small Molecule Libraries - pharmacology</subject><ispartof>Molecular and cellular endocrinology, 2019-04, Vol.485, p.20-34</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-699749063eae16391b275baea8f717cee58d8119c7845887a5df7a7dcbb2b1c43</citedby><cites>FETCH-LOGICAL-c396t-699749063eae16391b275baea8f717cee58d8119c7845887a5df7a7dcbb2b1c43</cites><orcidid>0000-0001-5675-511X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mce.2019.01.022$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30703487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meijer, Femke A.</creatorcontrib><creatorcontrib>Leijten-van de Gevel, Iris A.</creatorcontrib><creatorcontrib>de Vries, Rens M.J.M.</creatorcontrib><creatorcontrib>Brunsveld, Luc</creatorcontrib><title>Allosteric small molecule modulators of nuclear receptors</title><title>Molecular and cellular endocrinology</title><addtitle>Mol Cell Endocrinol</addtitle><description>Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry to address the need for small molecules targeting NRs in pathology, via novel modes of action and with beneficial profiles. In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs. Subsequently, the review focuses on examples of small molecules that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain. Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention. The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small molecular targeting of NRs. [Display omitted] •Allosteric small molecule modulation has emerged as novel entry to targeting NRs.•Inspiration for allosteric NR modulation can be found in other receptor classes.•Allosteric NR modulators harbor the potential for providing novel NR pharmacology.•Screening assays focused on identifying allosteric NR modulators are needed.</description><subject>Allosteric Regulation - drug effects</subject><subject>Allosteric Site</subject><subject>Allostery</subject><subject>Binding Sites</subject><subject>Drug Design</subject><subject>Drug discovery</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Ligands</subject><subject>Nuclear receptors</subject><subject>Receptors, Cytoplasmic and Nuclear - chemistry</subject><subject>Receptors, Cytoplasmic and Nuclear - metabolism</subject><subject>Small Molecule Libraries - pharmacology</subject><issn>0303-7207</issn><issn>1872-8057</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo7rr6A7xIj15aJ0nbSfAk4hcseNFzSNMpdEm3a9IK_nuzrHr0NMPwvC_Mw9glh4IDr282xeCoEMB1AbwAIY7YkisUuYIKj9kSJMgcBeCCncW4AQCshDplCwkIslS4ZPrO-zFOFHqXxcF6nw2jJzd7Sks7ezuNIWZjl21n58mGLJCj3f54zk466yNd_MwVe398eLt_ztevTy_3d-vcSV1Pea01lhpqSZZ4LTVvBFaNJas65OiIKtUqzrVDVVZKoa3aDi22rmlEw10pV-z60LsL48dMcTJDHx15b7c0ztEIjrqUWNc6ofyAujDGGKgzu9APNnwZDmZvzGxMMmb2xgxwk4ylzNVP_dwM1P4lfhUl4PYAUHrys6dgoutp66jtk4vJtGP_T_03_BV7gA</recordid><startdate>20190405</startdate><enddate>20190405</enddate><creator>Meijer, Femke A.</creator><creator>Leijten-van de Gevel, Iris A.</creator><creator>de Vries, Rens M.J.M.</creator><creator>Brunsveld, Luc</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5675-511X</orcidid></search><sort><creationdate>20190405</creationdate><title>Allosteric small molecule modulators of nuclear receptors</title><author>Meijer, Femke A. ; Leijten-van de Gevel, Iris A. ; de Vries, Rens M.J.M. ; Brunsveld, Luc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-699749063eae16391b275baea8f717cee58d8119c7845887a5df7a7dcbb2b1c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Allosteric Regulation - drug effects</topic><topic>Allosteric Site</topic><topic>Allostery</topic><topic>Binding Sites</topic><topic>Drug Design</topic><topic>Drug discovery</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Ligands</topic><topic>Nuclear receptors</topic><topic>Receptors, Cytoplasmic and Nuclear - chemistry</topic><topic>Receptors, Cytoplasmic and Nuclear - metabolism</topic><topic>Small Molecule Libraries - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meijer, Femke A.</creatorcontrib><creatorcontrib>Leijten-van de Gevel, Iris A.</creatorcontrib><creatorcontrib>de Vries, Rens M.J.M.</creatorcontrib><creatorcontrib>Brunsveld, Luc</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meijer, Femke A.</au><au>Leijten-van de Gevel, Iris A.</au><au>de Vries, Rens M.J.M.</au><au>Brunsveld, Luc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allosteric small molecule modulators of nuclear receptors</atitle><jtitle>Molecular and cellular endocrinology</jtitle><addtitle>Mol Cell Endocrinol</addtitle><date>2019-04-05</date><risdate>2019</risdate><volume>485</volume><spage>20</spage><epage>34</epage><pages>20-34</pages><issn>0303-7207</issn><eissn>1872-8057</eissn><abstract>Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry to address the need for small molecules targeting NRs in pathology, via novel modes of action and with beneficial profiles. In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs. Subsequently, the review focuses on examples of small molecules that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain. Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention. The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small molecular targeting of NRs. [Display omitted] •Allosteric small molecule modulation has emerged as novel entry to targeting NRs.•Inspiration for allosteric NR modulation can be found in other receptor classes.•Allosteric NR modulators harbor the potential for providing novel NR pharmacology.•Screening assays focused on identifying allosteric NR modulators are needed.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>30703487</pmid><doi>10.1016/j.mce.2019.01.022</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0001-5675-511X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0303-7207
ispartof Molecular and cellular endocrinology, 2019-04, Vol.485, p.20-34
issn 0303-7207
1872-8057
language eng
recordid cdi_proquest_miscellaneous_2179437669
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Allosteric Regulation - drug effects
Allosteric Site
Allostery
Binding Sites
Drug Design
Drug discovery
Gene Expression Regulation - drug effects
Humans
Ligands
Nuclear receptors
Receptors, Cytoplasmic and Nuclear - chemistry
Receptors, Cytoplasmic and Nuclear - metabolism
Small Molecule Libraries - pharmacology
title Allosteric small molecule modulators of nuclear receptors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A40%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allosteric%20small%20molecule%20modulators%20of%20nuclear%20receptors&rft.jtitle=Molecular%20and%20cellular%20endocrinology&rft.au=Meijer,%20Femke%20A.&rft.date=2019-04-05&rft.volume=485&rft.spage=20&rft.epage=34&rft.pages=20-34&rft.issn=0303-7207&rft.eissn=1872-8057&rft_id=info:doi/10.1016/j.mce.2019.01.022&rft_dat=%3Cproquest_cross%3E2179437669%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179437669&rft_id=info:pmid/30703487&rft_els_id=S0303720719300346&rfr_iscdi=true